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ABSTRACT 
Tyrosyl-DNA phosphodiesterase I (TDP1) plays an important role in repair of 
topoisomerase I-DNA complexes in vivo, and its inhibitors have the potential to enhance the 
efficacy of the Top1-targeting drugs in anticancer therapy. Nevertheless a large number of TDP1 
inhibitors have been reported, none of them has inhibition activity in vivo. We present a virtual 
screening protocol to explore potent TDP1-selective inhibitors.  
3-ketosteroid receptors belong to nuclear receptor family, and their DNA binding domains 
interact with glucocorticoid response elements (GREs) to regulate gene transcription. With 
evolution, all of them can bind to activating response element ((+)GRE), but only some exhibit 
the ability to bind to negative glucocorticoid response element (nGRE). It was found that 
evolutionary mutations are important to change their binding functions. We have presented 
dynamic network models to elucidate allosteric communication for selected evolutionary 
homologues, discussing the correlation between binding characteristics and epistatic mutations 
from network theory.  
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1 CHAPTER 1: DISCOVERY OF POTENT TYROSYL-DNA 
PHOSPHODIESTERASE 1 INHIBITORS USING IN SILICO VIRTUAL 
SCREENING  
1.1 INTRODUCTION 
1.1.1 Topoisomerase 1 and 2 (Top1 and Top2) 
In eukaryotes, dormant DNA is wound around histones in highly compact bodies known as 
nucleosomes, which must be unwound for replication and transcription. Unwinding of 
nucleosomal DNA by the cellular replication and transcription machinery can cause supercoiling. 
[1] In the confines of the nucleus, this supercoiling becomes a topological phenomenon and can 
only be relieved by topoisomerase activity. There are two general classes of topoisomerase: type 
I topoisomerases, of which human topoisomerase 1 (Topo1) is a member, cut a single strand of 
DNA, allowing superhelical tension to drive rotation about the uncleaved strand before finally 
religating the cut strand; and type II topoisomerases, of which human topoisomerase II (Topo2) 
is a member, cut both strands of a DNA duplex, while binding the DNA at another position, 
allowing the uncut DNA to pass through the cut site before reannealing the cut DNA. Both types 
of topoisomerase perform DNA scission via nucleophilic attack of a tyrosinate residue on a DNA 
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backbone phosphorus, resulting in a covalent tyrosine phosphodiester linkage between the 
topoisomerase and the cleaved DNA, with this linkage occurring on the 3’ and 5’ sides of the 
phosphate in type I and type II topoisomerases, respectively. [2]  
1.1.2 Topoisomerase as drug target 
Topoisomerase have become a popular target in anticancer therapy. Top1 and Top2 cleavage 
complexes (Top1cc and Top2cc) can be trapped, resulting in persistent single and double strand 
breaks, effectively blocking replication in rapidly dividing cancer cells and thereby inhibiting 
tumor growth and metastasis. [3] The efficacy of this class of anticancer drugs, known as 
topoisomerase poisons, is compromised by the activity of tyrosyl-DNA phosphodiesterases, 
enzymes capable of actively cleaving the covalent linkage between topoisomerases and their 
DNA substrates. [4] 
1.1.3 Tyrosyl-DNA phosphodiesterase 1 (TDP1) 
TDP1, first identified by Nash and coworkers in Saccharomyces cerevisiae, catalyzes the 
hydrolysis of the tyrosyl-phosphodiester bond in TopoI-DNA complexes (figure 1.1). [5] Human 
TDP1 is a 68 kDa monomer with a pseudo-2-fold axis of symmetry arranged in an α-β-α-β-α 
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sandwich (figure 1.2(a)). The N-terminus catalytic domain is from Gly149 to Thr350, and the 
C-terminus catalytic domain goes from Asn351 to Ser608. Each domain consists of one 
conserved HKN motif (His263, Lys265, Asn283, His493, Lys495, and N516 in the human TDP1; 
that belongs to the phospholipase D (PLD) superfamily to catalyze the repair of 3'-DNA adducts, 
and the detail TDP1’s reaction mechanism are shown in figure 1.3. [6] Two conserved HKN 
motifs are located in the center of the TDP1, forming a catalytic region inside an asymmetric 
substrate-binding channel (figure 1.2(b)). One side of the asymmetric channel is narrow and 
lined with positively charged distribution, and the other side is bowl-shaped basin with 
negatively charged distribution. According to the size and charged distribution, it implies the 
narrow side is a DNA binding region and the opened side is a polypeptide binding region. [7]  
1.1.4 Tyrosyl-DNA phosphodiesterase 2 (TDP2) 
By contrast to TDP1, TDP2, which is critical to repair topoisomerase II-induced DNA 
damage, is specific to cleave phosphotyrosyl bond at the 5’ DNA terminal (figure 1.4). [8, 9] 
Although the function of TDP2 is similar to TDP1 hydrolyzing the phosphotyrosyl bond and 
removing topoisomerase-DNA adduct, their catalytic mechanisms are different. TDP2 does not 
form the covalent intermediate but involves one divalent metal, Mg2+, for catalysis (figure 1.5). 
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[10] The 5’-DNA phosphate is stabilized by the magnesium, H236, S239, and H359, and a water 
molecule is deprotonated by D272 and acts as nucleophile to attack the 5’-DNA phosphate. So 
far, the crystal structure of human TDP2 has not been reported, so the TDP2 crystal structure 
presented here is from Mus musculus (figure 1.6). [10] 
1.1.5 Specific goal 
Tyrosyl-DNA phosphodiesterases 1 and 2 (TDP1 and TDP2) are DNA repair enzymes that 
repair trapped topoisomerase-DNA complexes by removing a blocking group at a 3’- and 
5’-DNA ends. [7, 11] It was found that TDP1 inhibitors can increase the lifetime of Top1 
cleavage complexes and therefore, the cytotoxicity of camptothecin in vivo, enhancing the 
activity of Top1 inhibitors in cancer cells. A compound with in vivo TDP1 inhibition activity has 
yet to be identified. Therefore, we have identified a number of potential drug candidates that 
have TDP1-selective inhibition to enhance the cytotoxicity of camptothecin in vivo.  
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1.2 METHOD 
1.2.1 Virtual Screening 
 Virtual screening is a computational technique applied on drug discovery to search libraries 
of known molecules in order to rapidly identify those molecules that can bind to a drug target. 
[12] The virtual screening protocol can be seen in figure 1.7.  
1.2.2 Model Construction 
 Model construction is useful to give us an idea about the 3-dimenstional structure and where 
the residues locate in the protein structure, and a complete protein structure can assistant us to 
study in dynamics, protein-ligand interaction, and drug discovery. Usually, some residues are not 
rigid in the crystal resulting in missing residues reported in the PDB files, and these residues may 
be critical to the biological function. Therefore, if there are empirical 3D protein structures that 
are similar to our target protein (template) with 50% or better sequence similarity, we can 
arrange the backbone of the similar sequence, place the missing residues or insert additional 
residues to our template. [13, 14] 
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1.2.3 Molecular dynamic simulations 
 The first application of Molecular Dynamics (MD) simulation was reported in the late 
1970s, and MD simulation has been vastly developed and become an extremely powerful tool 
applying on biochemistry and biology due to the advanced computation technologies and 
algorithmic improvements. [15] Many successful applications of MD simulations are shown to 
cover a broad spectrum of problems, such as allosteric properties, polypeptide folding, 
biomolecular association, and ion transport. [16-19] MD simulation reveals atomic-level detailed 
information to provide great assistance in interpreting experiment data that are not accessible to 
direct experimental measurement. Therefore, it is considered a significant method to study 
microstructure of materials. 
1.2.3.1 Amber Force Field 
In MD simulation, potential energy (V) is a function of the molecular parameters (R) to 
describe intra- and inter- molecular forces between atoms in the system. In order to easily be 
calculated on a computer, it includes many approximations to construct an additive formula 
called a force field, and this formula consist of several terms to provide contribution of bonded 
and non-bonded interactions.  
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(1.1)
 
The bonded interactions corresponding to bond length, angle, and dihedral parameters 
describe the ability of bonds to stretch, bend, and torsion, and the non-bonded interactions have 
two components, Columbic potential for electrostatic interactions and Lennard-Jones (LJ) 
potential for van der Waals interactions. In force field, parameters can be derived by fitting either 
experimental measurements, such as vibrational frequencies of molecules, potential energy 
surface, and dielectric permittivity etc., or quantum mechanical calculations. In this thesis, 
AMBER force field [20] used to carry out all simulations is as follows: 
    
(1.2)
 
The above potential energy function includes the first four terms for intra-molecular 
interactions and the last two terms for inter-molecular interactions. Parameters, 𝐾!, 𝐾!, 𝐾!, and 
𝐾!, account for the bond, angle, dihedral, and improper force constant. 𝑟 − 𝑟!" represents the 
changes in bond length and its equilibrium length. 𝜃 − 𝜃!"  is the angle from equilibrium 
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between three consecutive atoms. In the third term, 𝑛 is the multiplicity, 𝜙 is the dihedral 
angle, and 𝛿  is the phase shift. 𝜑 − 𝜑!"  is the changes in out-of-plane angle from its 
equilibrium state (figure 1.8). 
For two inter-molecular interactions, the first is using Lennard-Jones (LJ) potential to 
account for the attractive force, !!!" !, and repulsive force, !!!" !", between two particles, 
where 𝑟!" is the distance between these two particles, 𝜀!" is the Lennard-Jones well depth, and 
𝑅!"!"# is the distance between two particles at the minimum potential fitted from experiment data 
or quantum calculation. The second one is using Coulomb potential to describe electrostatic 
interaction, where  𝑟!" is the distance between atom 𝑖 and 𝑗, 𝑞! and 𝑞! are the point charges of 
them respectively, and 𝜀! is the effective dialectic constant.  
1.2.3.2 Integration of Newton’s equation 
After the determination of initial coordinates and velocities for a system of all atoms, a set of 
classical Newton’s equation of motion (eq. 1.3) was numerically integrated to obtain a trajectory 
over a period of time. 
                                                 
(1.3)
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In the eq. 1.3, 𝐹 is the force acting on an atom, 𝑚 is the mass of the atom, 𝑎 is the 
acceleration, and R is the position of the atom. The acceleration can be further expressed as the 
second derivative of the position of the atom with related time, 𝑡. The force also can be written 
as the gradient of the potential energy: 
                          
(1.4)
 
Therefore, the combination of eq. 1.3 and eq. 1.4 is obtained to describe the correlation 
between the derivative of the potential energy and the changes in position as a function of time: 
                             
(1.5)
 
 Once the forces acting on atoms are calculated, the accelerations of all atoms can be 
obtained. Subsequently, the new positions and velocities of the atoms can be derived within a 
short period of time (timestep). [21] According to the new positions, the forces on the atoms will 
be recalculated from the potential energy function, and these data, positions, velocities, and force, 
are calculated with iterative steps and saved for a certain time interval to obtain a trajectory of 
the system. In order to accurately simulate the fastest motion, the timestep is typically on the 
order of femtosecond (fs), because vibrational frequencies of the fastest motion involving heavy 
atom-hydrogen bonds in a molecular system corresponds to ~10 fs. Since simulations with short 
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timesteps are computationally expensive, one of the methods to improve and allow longer 
timesteps (2fs) [22] in MD simulation is SHAKE algorithm. SHAKE algorithm is applied to 
remove the highest vibrational frequency by constraining all bonds associated with hydrogen in 
the system, and it is based on Verlet integration algorithm [23] derived from two Taylor 
expansions shown as follows: 
                   
(1.6)
 
                   
(1.7)
 
In these expansions, 𝑟!  is the position at the nst timestep, 𝑟!!!  is the position at its 
previous timestep, and 𝑟!!! is the position at its next timestep. O ∆𝑡!  is the function of ∆𝑡 
with n order or higher order. These two expansions can be added to obtain equation 1.8. 
                    (1.8) 
According to the eq. 1.8, the new atomic position at n+1st timestep is determined from the 
current position and force exerted on the atom at nst timestep, and its prior position at n-1st 
timestep. 
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1.2.3.3 Non-bonded interactions 
In most MD simulations, the systems contain solvent molecules with thousands of atoms, 
and the computation of non-bonded interactions for these large molecular systems is 
prohibitively slow due to the number of pair interactions grows on the order of !!!!! . To 
reduce the computational costs for performing the non-bonded interactions, there are several 
methods have been developed. [24] 
1.2.3.4 Cutoffs 
With the increase of distance between two particles, van der Waals interactions represented 
by the Lennard-Jones potential decay rapidly. When σ is defined as a finite distance between two 
interacting atoms at which the inter-atomic potential is zero, the van der Waals interaction at a 
distance of 2.5 σ is only 1% of the interaction at σ. [25] Therefore, a straight cutoff truncation is 
frequently applied on Lennard-Jones potential. In MD simulations, the Lennard-Jones interaction 
is neglected when the distances of pairs of all atoms are greater than a certain distance referred to 
the cutoff distance.   
In order to avoid the abrupt truncation and obtain a smooth decay at the cutoff distance, 
shifted potential function or switching function is introduced. For shifted potential function, the 
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potential is slightly shift in the entire range of distance, so the potential value at the cutoff 
distance is zero to maintain the continuity. For the switching function, a modified potential 𝑆(𝑟) 
is used to bring the potential gradually approaching to zero within a interval, and usually the 
interval is 1-2 Å.[26] 
1.2.3.5 Long-range electrostatic interaction 
 The cutoff methods also are applied on electrostatic interactions. However, it was found that 
the long-range electrostatic interactions are important in the biological systems because of its 
slowly decay (~1/R), so the truncation of long-range electrostatic interactions causes large 
computational errors and inaccuracy that are not acceptable to describe the protein and nucleic 
acid dynamics. [27] Therefore, treatments to correct long-range electrostatic interactions have 
been introduced, and Ewald summation is a most popular method to calculate electrostatic 
interactions in MD simulations. 
 The total energy in the Ewald summation method [28] includes the direct space energy 
(Edir), the reciprocal space energy (Erec), and the self energy (Ecorr). These three energies are show 
as follows: 
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(1.9)
 
(1.10)
 
(1.11)
 
Here,  𝛽 represents the Ewald parameters, 𝑉 is the volume of the unit cell, 𝑚 is lattice 
vector (m1, m2, m3) in reciprocal space, and 𝑆 𝑚  is the lattice structure factor. 
(1.12) 
The scale of Ewald summation is O(N2) in the system with N atoms, so it is computationally 
expensive. The Particle Mesh Ewald (PME) method reduces the Ewald summation to O(Nlog(N)) 
[29]. In PME method, a three-dimenstional grid is generated over the system, and the atomic 
charge is mapped on the grid; a fast fourier transforms is used to evaluate the summation of these 
grid points efficiently. In addition, incorporating an infinite number of unit cells in PME simply 
involves extrapolating the fourier series to infinity. [30, 31]  
1.2.3.6  Temperature control- Langevin thermostat 
 In MD simulation, the total energy of the system is conserved. If the total number of atoms 
(N) and the volume of the unit cell (V) are fixed, the MD simulation is considered being 
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conducted in the NVE ensemble also called microcanonical ensemble. An ensemble is a large 
collection of different microstates with an identical macroscopic in a system. For different 
situations, the MD simulation can be conduced in NVT (fixed number of atoms, fixed volume, 
and fixed temperature) or NTP ensemble (fixed number of atoms, fixed temperature, and fixed 
pressure). Therefore, the temperature should be controlled in MD simulations. In this thesis, an 
essential method used to maintain constant temperature is Langevin dynamics. [32]  
 In the Langevin dynamics, all atoms receive a random force and a friction force at each step, 
and these forces are related to the fluctuation-dissipation theorem to ensure sampling of the NVT 
statistics. Instead of the Newton’s equations, the dynamics of atoms is described by the 
Langevin’s equation [33] shown as follows: 
(1.13)
 
Here, 𝑚 is the mass of the particle, 𝑈 represents the particle interaction potential, 𝛤 is a 
friction coefficient,  is the velocity,  is the acceleration, and 𝑊!(𝑡) is the random force 
determined from a Gaussian distribution. 𝑊!(𝑡) varies by the desired temperature and timestep 
and it is balances with the friction force to keep the system temperature. 
 !r  !!r
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1.2.3.7  Pressure control 
 In the NPT ensemble, pressure is fixed, so the volume of the unit cell is allowed to fluctuate 
in the simulated system. Usually, the pressure is calculated via the virial theorem of Causius. 
[34] 
(1.14) 
𝑉 is the volume of the unit box, 𝐸!"#$%"& is the kinetic energy, and 𝛯 is the inner virial 
tensor for pair-additive potentials further described as: 
(1.15)
 
Here, 𝑓 𝑟!"  is the force on particle i caued by particle j, and 𝑟!" is the distance between 
the particle i and the particle j. When the system is treated as an isotropic manner, the pressure is 
a scalar quantity and can be expressed as: 
(1.16)
 
It is common to correct the pressure through a change in the inner virial 𝛯 by scaling the 
distances of inter particle. For Nosé-Hoover Langevin piston barostat, an additional degree of 
freedom, a piston (𝜎), is introduced into the equation of motion of each atom to vary the volume 
of the unit cell for controlling pressure. [35]  
16 
 
 
1.2.4  Docking 
 Docking is a computational technique that can place one ligand with the receptor in possible 
binding forms with optimal interactions. In docking, a bounding box is set to define a space 
where the ligand can bind to the target receptor, and the possible binding conformations and 
poses of the ligand can be sampled and ranked by calculating the estimated binding free energy 
of the receptor-ligand complex, so we can predict which binding mode is the most predominant 
with three-dimensional structure. Normally, the ligand-binding site of the target biomolecule 
could be a catalytic site in the enzyme, so the knowledge about the catalytic mechanism of 
biological processes for the target biomolecule can provide insights to determine the size and the 
position of the bounding box for docking ligands into the ligand-binding domain. [36] 
For docking, there are some inherent limitations. Typically, ligands with rotatable bonds are 
allowed to have different conformational changes, but the target molecules, such as protein, are 
treated as a rigid body. When the target molecules are kept in a particular conformation, docking 
algorithms may predict about 50% ~ 70% incorrect binding modes or energies. [37] In addition, 
the semi-empirical force field is used to calculate the binding free energy that is less accurate 
than the purely force field-based method, such as molecular dynamics, and some empirical 
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parameters in the program are determined from known structures leading to the inaccurate scores. 
Furthermore, the solvent effect is not adequately applied on the receptor-ligand system even if 
the solvent plays a significant role in the binding system. [36]  
1.2.5  Molecular mechanic-Poisson Boltzmann surface area (MM-PBSA) calculation 
 The binding free energy of ligand to protein can be predicted by MM-PBSA calculation 
with MD trajectories. [38] In ideal condition, the binding free energy of ligand to protein is 
evaluated by calculating the difference of free energy between unbound and bound two 
molecules in solvated state.  
              ∆𝐆𝐛𝐢𝐧𝐝,𝐬𝐨𝐥𝐯   =   ∆𝐆𝐜𝐨𝐦𝐩𝐥𝐞𝐱,𝐬𝐨𝐥𝐯   −   ∆𝐆𝐩𝐫𝐨𝐭𝐞𝐢𝐧,𝐬𝐨𝐥𝐯   −   ∆𝐆𝐥𝐢𝐠𝐚𝐧𝐝,𝐬𝐨𝐥𝐯           (1.17) 
However, a large number of solvent molecules occupy in the system, so solvent effects on 
solvent-solvent interactions and fluctuations are major energy contribution rather than the 
binding energy. Thus MM-PBSA is an effective method to calculate binding free energy as the 
following equation. [39] 
    ∆𝑮𝒃𝒊𝒏𝒅,𝒔𝒐𝒍𝒗   =   ∆𝑮𝒃𝒊𝒏𝒅,𝒗𝒂𝒄   +   ∆𝑮𝒄𝒐𝒎𝒑𝒍𝒆𝒙,𝒔𝒐𝒍𝒗   −   ∆𝑮𝒑𝒓𝒐𝒕𝒆𝒊𝒏,𝒔𝒐𝒍𝒗   −   ∆𝑮𝒍𝒊𝒈𝒂𝒏𝒅,𝒔𝒐𝒍𝒗      (1.18) 
∆𝐺!"#$,!"#$  and ∆𝐺!"#$,!"# represent the binding free energies in the solvated and vacuum 
system, and ∆𝐺!"#$%&',!"#$, ∆𝐺!"#$%&',!"#$, and ∆𝐺!"#$%&,!"#$  represent the solvation free energy 
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for complex, protein, and ligand. The solvation free energy contains the contribution of the 
electrostatic interaction and hydrophobic interaction.  
                            ∆𝑮𝒔𝒐𝒍𝒗   =   ∆𝑮𝒔𝒐𝒍𝒗,𝒆𝒍𝒆𝒄𝒕𝒓𝒐𝒔𝒕𝒂𝒕𝒊𝒄   +   ∆𝑮𝒔𝒐𝒍𝒗,𝒉𝒚𝒅𝒓𝒐𝒑𝒉𝒐𝒃𝒊𝒄                    (1.19) 
Poisson Boltzmann (PB) approach was used to solve the electrostatic contribution of the 
solvation free energy ∆𝐺!"#$,!"!#$%&'$($)#, and the hydrophobic contribution was calculated from 
the surface area (SA). Under the constant temperature condition, the vacuum binding free energy 
can be defined as 
                        ∆𝑮𝒃𝒊𝒏𝒅,𝒗𝒂𝒄   =   ∆𝑬𝒃𝒊𝒏𝒅,𝒗𝒂𝒄   −   𝑻∆𝑺                               (1.20) 
In the eq. 1.20, ∆𝐸!"#$,!"#, which includes molecular mechanics bond energy, molecular 
mechanics van der Waals energy, and molecular mechanics electrostatic energy, is the binding 
free energy between ligand and receptor in vacuum, and ∆S is the entropy change upon binding 
in vacuum. According to the eq. 1.19 and eq. 1.20, the binding free energy can be described by 
the eq. 1.21. 
               ∆𝑮𝒃𝒊𝒏𝒅,𝒔𝒐𝒍𝒗   =   ∆𝑬𝒃𝒊𝒏𝒅,𝒗𝒂𝒄   +   ∆𝑮𝑷𝑩   +   ∆𝑮𝑺𝑨   −   𝑻∆𝑺              (1.21) 
19 
 
 
1.2.6  Tanimoto similarity with ROCS and EON 
Proteins (enzymes, receptors, etc.) recognize ligands or inhibitors by their shape and charge. 
Ligand based virtual screening techniques can identify new scaffolds that can bind to the same 
pocket with similar overall shape and charge distribution. After running the MD simulation, we 
obtained the possible configurations of shape and charge to run virtual screening by ROCS 
(Rapid Overlay of Chemical Structures) and EON (electrostatics comparison program) basing on 
Tanimoto measurement. [40, 41] First, an ensemble of ligand conformations was generated for 
all compounds in NCI database by program OMEGA [42], and query molecule and database 
conformer are aligned by a solid-body optimization process with ROCS (figure 1.9). After 
aligning their shape, EON, an, was used to compare electrostatic potential maps of these aligned 
molecules and determine the Tanimoto measurement for finding the potent inhibitors. 
Tanimoto measurement is used in the comparison of sets of 3D parameters, and it involves 
comparing properties for two compounds with the overlap of those properties. Shape functions 
for A and B are compared with the overlap between the two shape functions after alignment to 
give Shape Tanimoto values that approach 0.0 for dissimilar and 1.0 for similar shapes (eq. 1.22). 
Poisson-Boltzman electrostatic field functions for A and B are compared with overlap between 
20 
 
 
fields to give Electrostatic Tanimoto values that approach -1/3 for opposite and 1.0 for similar 
field overlaps (eq. 1.23) 
(1.22) 
(1.23) 
1.2.7 Trajectory Analysis 
1.2.7.1 RMSD 
 The Root Mean Square Deviation (RMSD) [43] is a measurement of differences between 
two values, and it is frequently used to calculate the structural similarity between two 
macromolecules. To achieve the minimal RMSD, an optimal superposition of structures is 
necessary to eliminate the deviations from translation and rotation, and RMSD can be defined 
by: 
(1.24)
 
Here, 𝑁 is the total number of selected atoms in a reference or instantaneous configuration, 
𝑟!! is the coordinates of nth atom for ith conformation of the macromolecule, and 𝑟!! is the 
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coordinates of nth atom for jth conformation of the macromolecule. Usually, the changes in the 
order of 1-3 Å are acceptable for small proteins. 
1.2.7.2  RMSF 
 The Root Mean Square Fluctuation (RMSF) [44] is the standard deviation between the 
position of the residue i and the position of residue i from the average structure to measure the 
local chain flexibility. 
(1.25) 
Here, 𝑇 is the trajectory time, 𝑟!!"# is the time-averaged position of the residue 𝑖,  𝑟!(𝑡) is 
the position of the residue i at time 𝑡. 
1.3 EXPERIMENTAL PROCEDURE 
To construct a TDP1 model, the protein structures of human TDP1 were obtained from the 
RCSB Protein Data Bank (PDB code: 1RG1, 1JY1, 1QZQ). Holo-form TDP1 (1RG1) was used 
as the template structure, and missing residues 124-161 were added from 1JY1, residues 387-390 
were added from 1RG1 chain B, and residues 425-434 were added from 1QZQ chain A in 
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PyMOL. Missing loops between residues 560-568 were built with the program ModLoop: 
automated modeling of loops in protein structures bioinformatics.[45, 46] 
 Flexible docking was applied for docking leading compound to our TDP1 model in 
Autodock 4.2.[47] The Lamarckian genetic algorithm was used for two hundreds runs, and the 
grid box was centered at the middle of the DNA-protien binding cleft. 
 Simulations were performed using the AMBER ff99SB forcefield, in the NAMD2.9 [48] 
molecular dynamics program. Bonded and short-range interactions were evaluated every 2fs, 
with long-range electrostatics evaluated every 4 fs with the smooth particle mesh ewald method. 
[49]  Short-range nonbonded interactions were evaluated using a 10Å cutoff with a switching 
function at 8.5 Å. The r-RESPA [50] multiple timestep integration scheme was employed with a 
2fs timestep and SHAKE employed to fix bonds between hydrogens and heavy atoms. Partial 
charges for ligands were computed via Gaussian geometry optimization, followed by RESP 
fitting of the resultant Mulliken population analysis in the program antechamber, a component of 
the AMBER computational chemistry suite. Atom types were automatically generated for the 
ligand in antechamber, with atomic parameters taken from the generalized amber force field 
(GAFF).  System preparation was performed in the xLEaP program, with a TIP3P water solvent 
23 
 
 
box extended 10A in every direction from the protein-ligand complex and Na+ and Cl- ions 
added to 0.15M. The equilibration protocol consists of 5000-steps of steepest descent energy 
minimization, with positional constraints placed on solvent atoms, followed by another 
5000-steps of conjugated gradient minimization without positional restraints. The system was 
then simulated for 100-ps in the canonical ensmble, while heating from 0 to 300 K with 
positional restraints on all solute heavy atoms. Finally, the system was simulated in the 
isothermal-isobaric ensemble for 2 ns with positional restraints on protein backbone atoms only. 
The system was sampled in the isothermal-isobaric ensemble for 100 ns for analysis. 
1.4  RESULTS AND DISCUSSION 
1.4.1 Docking of NSC339616 to TDP1 
 The leading compound, NSC 339616, we used for docking was discovered by using virtual 
screening from 265,000 NCI compounds, and it was found that the compound is a selective 
inhibitor of TDP1 according to the gel assay (figure 1.10). Our docking results indicate that 
NSC339616 likely binds either directly to the active site or to the DNA-binding cleft of TDP1. 
Molecular dynamics simulations, as previously described, were carried out on the top 4 docking 
poses (figure 1.11) to determine which of the binding sites is most likely to be observed 
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experimentally, as well as determine the dominant conformation of the bound ligand. The 
relative stability of each complex was monitored by RMSD. As seen in figure 1.12, binding of 
ligand to the DNA-binding cleft greatly reduces conformational flexibility in that region of the 
protein. The evidence for regional conformational stabilization by DNA-binding cleft 
interactions with the ligand is further compounded by the RMSF plots in figure 1.13. Major 
reductions in RMSF in bining pose 1 (BP1) relative to binding pose 2 (BP2) occur mostly in a 
flexible loop near the binding site, indicating that closure of this loop over the cleft is a direct 
result of ligand binding (figure 1.14). 
15,000 evenly spaced frames from the MD trajectories were clustered to identify the 
kinetically dominant binding pose (figure 1.15). BP1 exhibits hydrogen bonding from 
NSC339616 to Ser363 and Gln365, with Phe159 stacking over the aliphatic portion of the 
compound to stabilize loop closure. In BP2, NSC339616 forms hydrogen bonds to Lys265 and 
Asn139 as well as nonpolar interactions with Tyr104. 
1.4.2 Binding free energy calculation 
 To distinguish between the active site and DNA-binding cleft ligand binding sites, PBSA 
calculations were performed over 1,200 frames of each trajectory. BP1 is the more favorable of 
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the two poses, at ~7 kcal/mol lower than BP2, with Van der Waals and electrostatic contributions 
indicating stronger protein-ligand interactions. 
Table 1.1 Comparison of MM-PBSA results for ligand bound in DNA binding site and 
active binding site. 
 DNA binding site Active site 
Van der Waals contribution 
(kcal/mole) 
-29.0±2.4 -25.6±2.6 
Electrostatic energy 
(kcal/mole) 
-41.3±2.7 -34.7±2.5 
Electrostatic contribution to 
the solvation free energy 
(kcal/mole) 
40.2±2.1 34.0±1.8 
Nonpolar contribution to the 
solvation free energy 
(kcal/mole) 
-21.6±1.2 -19.7±1.3 
Dispersion solvation energy 
(kcal/mole) 
37.3±1.7 39.0±1.8 
Delta G (kcal/mole) -14.3±2.3 -6.9±2.7 
 
 In order to clarify detailed interactions that stabilize NSC339616, the protein-ligand 
interaction energies were decomposed into each residue [51], and residues with significant 
contributions are shown in figure 1.16. Compared to binding pose 2, more residues provide 
interaction to stabilize NSC339616 in the DNA binding site. 
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1.4.3 Similarity search with 3D shape and electrostatic comparison 
The NSC339616 conformation in BP1 was used to perform shape- and electrostatics-based 
screening against the NCI small molecule library. 10,000 potential analogues were identified and 
ranked by linear combination of their electrostatic and shape Tanimoto scores. The top six 
compounds in this ranking are displayed as shape- and electrostatic overlays with NSC339616 in 
figures 1.17 and 1.18.  
1.5 CONCLUSIONS 
The development of TDP1 and TDP2 selective inhibitors is a very attractive therapeutic goal, 
given that such an inhibitor could be used in conjunction with topoisomerase poisons, leading to 
higher rates of clinical success in cancer patients who have been prescribed topoisomerase 
poisons. Using NSC339616 as a lead compound, we have identified 6 potential inhibitor 
candidates and determined that flexibility in the DNA-binding cleft of TDP1 can be exploited as 
a binding site for small molecules. Further cycles of virtual screening against these 6 compounds 
could lead to the discovery of a potent and selective TDP1 inhibitor. 
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Table 1.2 Comparison of TDP1 and TDP2. 
 TDP1 TDP2 
Family Phospholipase D (PLD) 
Exonuclease-endonuclease- 
phosphatase (EEP) 
Catalytic 
mechanism 
Covalent intermediate Metal catalysis 
Conserved motifs HKN TWN, LQE, GDXN, and SDH 
Cleavage activity Tyrosine from the 3’-DNA end Tyrosine from the 5’-DNA end 
Associate disease SCAN1 Parkinson disease 
 
 
Figure 1.1 The repair of the topoisomerase I-mediated DNA damage by TDP1. 
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Figure 1.2 Crystal structure of human TDP1 (PDB ID: 1RG1). 
 (a) TDP1 structure is shown in ribbon. Each N-terminal (cyan) and C-terminal (yellow) 
provides one HKN motif in the center of the TDP1. (b) The structure is colored by electrostatic 
potential (blue in positive and red is negative). Left side with narrow channel and positive charge 
is DNA binding site, and the right side with bowl shape and negative charge is peptide-binding 
site. 
 
 
 
 
(a)  (b)  
Asn283 
Lys265 His263 
Asn516 
Lys495 His493 
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His263 
Glu538 
His493 
Top1-Tyr His263 
Glu538 
His493 
Top1-Tyr His263 
Glu538 
His493 
His263 
Glu538 
His493 
Top1-Tyr 
His493 
Glu538 
His263 
 
 
Figure 1.3 Catalytic mechanism of TDP1. 
At the beginning, His263 residue attacks phosphotyrosyl bond between the Top1-DNA complex, 
and His493 residue protonates the tyrosine-containing leaving group to cleave the 
phosphodiester bond with the formation of the transient covalent phosphoamide bond. The 
negatively charged residue of Glu538 stabilizes the hydrogen on imidazole ring of His263 to 
keep the proximal nitrogen acting as a nucleophile. Next, the His493 residue from the C-terminal 
domain acts as a general base to active a water molecule that hydrolyzes the covalent 
intermediate. [7, 52] 
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Figure 1.4 The repair of the topoisomerase II-mediated DNA damage by TDP2. 
 
 
Figure 1.5 The proposed catalytic mechanism for TDP2 to cleave phosphodiester bond. 
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Figure 1.6 Crystal structure of human TDP2 (PDB ID: 4GZ1). 
(a) TDP2 structure is shown in ribbon. Catalytic residues, N130, D132, E162, D272, N274, and 
H359, are shown in sticks in the center of the TDP2. (b) The structure is colored by electrostatic 
potential (blue in positive and red is negative). Similarly to TDP1, left side with positive charge 
is DNA binding cleft, and the right side negative charge is catalytic region. 
 
(a)  (b)  
E162 D272 
N274 
H359 
N130 
D132 
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Figure 1.7 Virtual Screening Protocol. 
 
Figure 1.8 Intra- and inter- molecular interactions. 
(a) bond stretching, (b) angle bending, (c) torsional angle, (d) improper anagle, (e) van der Waals, 
and (f) electrostatic interactions. 
(a)  (b)  
(d)  (c)  
(e)  (f)  
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Figure 1.9 Basic ideal of Tanimoto similarity. 
We begin with a query molecule and a database molecule, align these two molecules, and 
overlay two molecules basing on their centers of mass and aligning along principle moment of 
inertia. From this point, the maximized overlap volume was optimized between query and 
database molecules, and we can compute the shape Tanimoto score. 
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Figure 1.10 TDP1 and TDP2 gel assay. 
(a) Both TDP1 and TDP2 cleave a tyrosine residue at the 3’- and 5’-end of single-stranded 
oligonucleotides respectively. (b) NSC339616 was tested on a dose response (0.46, 1.4, 4.1, 12.3, 
37, 111µM) with 5 pM hTDP1 in LMP1 buffer. (left gel) and on a dose response (12.3, 37, 
111µM ) with hTDP2 in LMP2 buffer. (right gel) Representative gels show NSC339616 is a 
TDP1-selective inhibitor. 
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Figure 1.11 Four representative docking poses of NSC339616 in TDP1 model. 
Both the DNA and the active site with positive charge distribution are available providing 
electrostatic interaction to stabilize our leading compound with -1 charge. The estimated binding 
free energy for 1~4 binding poses are -6.26, -6.19, -5.75, and -5.63 kcal/mol, respectively. TDP1 
structure is colored by electrostatic potential (blue in positive and red is negative).  
 
 
 
Active site DNA binding cleft 
1 4 
2 
3 
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Figure 1.12 Changes of RMSD of two binding pose as a function of time from MD 
simulation. 
 
Figure 1.13 RMSD profiles in two binding poses 
− Binding pose 1 (DNA site) 
− Binding pose 2 (active site) 
 
− Binding pose 1 (DNA site) 
− Binding pose 2 (active site) 
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Figure 1.14 Comparison of TDP1 structures for (a) binding pose 1, (b) binding pose 2. 
(a,b) The structure is colored by RMSF, and the highlight loop locating in the DNA binding site 
shows different flexibilities between two binding poses. Blue region means less fluctuation, and 
(a)  (b)  
(c)  (d)  
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red area indicates more fluctuation. (c,d) NSC339616 in the DNA binding site induces the 
flexible loop become closer.  
 
 
Figure 1.15 Binding properties of two binding poses in TDP1 model. 
(a) Binding pose 1 and (b) binding pose 2. Hydrogen bonds are drawn in cyan line. NSC339616 
is shown in yellow sticks, and residues within 3.0 Å of the ligand are shown in tan sticks. 
(Yellow is C, blue is N, green is F, and lime is Cl.) The structure is colored by RMSF (blue 
region means less fluctuation, and red area indicates more fluctuation). 
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Figure 1.16 Ligand-residue interactions from MM-PBSA energy decomposition for binding 
poses 1 (a) and 2 (b) in TDP1 model. 
TDP1 structure is colored by the values of interaction contribution from red (more contribution) 
to blue (less contribution). 
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Figure 1.17 Virtual screening with ROCS. 
The shape Tanimoto scores of compounds are followed as: 1: 0.849, 2: 0.799, 3: 0.771, 4: 0.765, 
5: 0.756, and 6: 0.754. The template is shown in green, and hits are shown in blue. The shapte 
Tanimoto score ranges from 0(non-identical) to 1(identical).  
 
 
 
 
 
 
 
 
1 2 3
4 5 6
1  2  3  
4 5 6 
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Figure 1.18 Virtual screening with EON. 
The EON_ET_combo scores of compounds are followed as: 1: 1.71, 2: 1.665, 3: 1.610, 4: 1.596, 
5: 1.594, and 6: 1.589. The are colored by electrostatic potential. Electrostatic Tanimoto combo 
score (ET_combo) that is the sum of the Shape Tanimoto and the Electrostatic Tanimoto, ranges 
from -1/3 (non-identical) to 2 (identical) values resulting from the overlap of charge and shape 
matches. TDP1 potent inhibitors are shown in molecular surface and colored by electrostatic 
potential (blue in positive and red is negative). 
Leading compound
3
6
1 2
4 5
Leading compound 
1  2  3  
4 5 6 
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Figure 1.19 Top six potent TDP1 inhibitors. 
 
 
 
 
 
 
N
N
OH
O
O
O
O
O
ON
N
OHO
O
N
O
O N
O
N
O
O
O O
O
OO
O
O
NCI 134141 NCI 11713 NCI 89112
NCI 147740 NCI 19891NCI 51480
NCI 13414 NCI 11713 NCI 89112 
NCI 147740 NCI 51480 NCI 19891 
43 
 
 
REFERENCE 
1. Leppard, J.B. and J.J. Champoux, Human DNA topoisomerase I: relaxation, roles, and 
damage control. (0009-5915 (Print)). 
2. Kato, S. and A. Kikuchi, DNA topoisomerase: the key enzyme that regulates DNA super 
structure. Nagoya J Med Sci, 1998. 61(1-2): p. 11-26. 
3. JA, H., DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic. 
Curr Med Chem Anticancer Agents., 2001. 1(1): p. 1-25. 
4. Malik, M. and J.L. Nitiss, DNA Repair Functions That Control Sensitivity to 
Topoisomerase-Targeting Drugs. Eukaryotic Cell, 2004. 3(1): p. 82-90. 
5. Comeaux, E.Q. and R.C. van Waardenburg, Tyrosyl-DNA phosphodiesterase I resolves both 
naturally and chemically induced DNA adducts and its potential as a therapeutic target. Drug 
Metab Rev, 2014. 46(4): p. 494-507. 
6. Interthal, H., J.J. Pouliot, and J.J. Champoux, The tyrosyl-DNA phosphodiesterase Tdp1 is a 
member of the phospholipase D superfamily. Proc Natl Acad Sci U S A, 2001. 98(21): p. 
12009-14. 
44 
 
 
7. Davies, D.R., et al., The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. 
Structure, 2002. 10(2): p. 237-48. 
8. Cortes Ledesma, F., et al., A human 5'-tyrosyl DNA phosphodiesterase that repairs 
topoisomerase-mediated DNA damage. Nature, 2009. 461(7264): p. 674-8. 
9. Nitiss, J.L. and K.C. Nitiss, Tdp2: a means to fixing the ends. PLoS Genet, 2013. 9(3): p. 
e1003370. 
10. Schellenberg, M.J., et al., Mechanism of repair of 5'-topoisomerase II-DNA adducts by 
mammalian tyrosyl-DNA phosphodiesterase 2. Nat Struct Mol Biol, 2012. 19(12): p. 
1363-71. 
11. Shi, K., et al., Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2. Nat 
Struct Mol Biol, 2012. 19(12): p. 1372-7. 
12. Reddy, A.S., et al., Virtual screening in drug discovery -- a computational perspective. Curr 
Protein Pept Sci, 2007. 8(4): p. 329-51. 
13. Chothia, C. and A.M. Lesk, The relation between the divergence of sequence and structure 
in proteins. The EMBO Journal, 1986. 5(4): p. 823-826. 
45 
 
 
14. Kaczanowski, S. and P. Zielenkiewicz, Why similar protein sequences encode similar 
three-dimensional structures? Theoretical Chemistry Accounts, 2010. 125(3-6): p. 643-650. 
15. McCammon, J.A., B.R. Gelin, and M. Karplus, Dynamics of folded proteins. Nature, 1977. 
267(5612): p. 585-590. 
16. Beckford, S.J. and D.W. Dixon, Molecular dynamics of anthraquinone DNA intercalators 
with polyethylene glycol side chains. J Biomol Struct Dyn, 2012. 29(5): p. 1065-80. 
17. Meng, H., et al., Molecular dynamics simulation of the allosteric regulation of eIF4A protein 
from the open to closed state, induced by ATP and RNA substrates. PLoS One, 2014. 9(1): p. 
e86104. 
18. Khalili-Araghi, F., et al., Molecular dynamics simulations of membrane proteins under 
asymmetric ionic concentrations. J Gen Physiol, 2013. 142(4): p. 465-75. 
19. Seibert, M.M., et al., Reproducible polypeptide folding and structure prediction using 
molecular dynamics simulations. J Mol Biol, 2005. 354(1): p. 173-83. 
20. Perez, A., et al., Refinement of the AMBER force field for nucleic acids: improving the 
description of alpha/gamma conformers. Biophys J, 2007. 92(11): p. 3817-29. 
46 
 
 
21. Schlick, T., E. Barth, and M. Mandziuk, Biomolecular dynamics at long timesteps: bridging 
the timescale gap between simulation and experimentation. Annu Rev Biophys Biomol 
Struct, 1997. 26: p. 181-222. 
22. Ryckaert, J.-P., G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the cartesian 
equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal 
of Computational Physics, 1977. 23(3): p. 327-341. 
23. Verlet, L., Computer "Experiments" on Classical Fluids. I. Thermodynamical Properties of 
Lennard-Jones Molecules. Physical Review 1967. 159: p. 98-103. 
24. Stone, A.J., The Theory of Intermolecular forces. 1996: Clarendon Press. 
25. Toxvaerd, S. and J.C. Dyre, Communication: Shifted forces in molecular dynamics. The 
Journal of Chemical Physics, 2011. 134(8): p. 081102. 
26. Wu, X.-W. and S.-S. Sung, Constraint dynamics algorithm for simulation of semiflexible 
macromolecules. Journal of Computational Chemistry, 1998. 19(14): p. 1555-1566. 
27. Brooks, C.L., B.M. Pettitt, and M. Karplus, Structural and energetic effects of truncating 
long ranged interactions in ionic and polar fluids. The Journal of Chemical Physics, 1985. 
83(11): p. 5897-5908. 
47 
 
 
28. Ewald, P.P., Die Berechnung optischer und elektrostatischer Gitterpotentiale. Annalen der 
Physik, 1921. 369(3): p. 253-287. 
29. Darden, T., D. York, and L. Pedersen, Particle mesh Ewald: An N⋅log(N) method for Ewald 
sums in large systems. The Journal of Chemical Physics, 1993. 98(12): p. 10089-10092. 
30. Patel, S. and C.L. Brooks, 3rd, CHARMM fluctuating charge force field for proteins: I 
parameterization and application to bulk organic liquid simulations. J Comput Chem, 2004. 
25(1): p. 1-15. 
31. Patel, S., A.D. Mackerell, Jr., and C.L. Brooks, 3rd, CHARMM fluctuating charge force 
field for proteins: II protein/solvent properties from molecular dynamics simulations using a 
nonadditive electrostatic model. J Comput Chem, 2004. 25(12): p. 1504-14. 
32. Schlick, T., Molecular Modeling and Simulation. 2002: Springer. 
33. Hünenberger, P., Thermostat Algorithms for Molecular Dynamics Simulations, in Advanced 
Computer Simulation, C. Dr. Holm and K. Prof. Dr. Kremer, Editors. 2005, Springer Berlin 
Heidelberg. p. 105-149. 
34. Martyna, G.J., D.J. Tobias, and M.L. Klein, Constant pressure molecular dynamics 
algorithms. The Journal of Chemical Physics, 1994. 101(5): p. 4177-4189. 
48 
 
 
35. Feller, S.E., et al., Constant pressure molecular dynamics simulation: The Langevin piston 
method. The Journal of Chemical Physics, 1995. 103(11): p. 4613-4621. 
36. Huang, S.Y. and X. Zou, Advances and challenges in protein-ligand docking. Int J Mol Sci, 
2010. 11(8): p. 3016-34. 
37. Totrov, M. and R. Abagyan, Flexible ligand docking to multiple receptor conformations: a 
practical alternative. Curr Opin Struct Biol, 2008. 18(2): p. 178-84. 
38. Archontis, J.M.H.a.G., MM-GB(PB)SA Calculations of Protein-Ligand Binding Free 
Energies. 2012. 
39. Homeyer, N. and H. Gohlke, Free Energy Calculations by the Molecular Mechanics 
Poisson−Boltzmann Surface Area Method. Molecular Informatics, 2012. 31(2): p. 114-122. 
40. Fe, S., EON 2.2.0.5: OpenEye Scientific Software, http://www.eyesopen.com. 
41. Fe, S., ROCS 3.2.0.4: OpenEye Scientific Software, http://www.eyesopen.com. 
42. Hawkins, P.C.D.S., A.G.; Warren, G.L.; Ellingson, B.A.; Stahl, M.T., OMEGA 2.5.1.4: 
OpenEye Scientific Software, http://www.eyesopen.com. 
43. Root Mean Square Deviation (RMSD), in Encyclopedia of Statistical Sciences. 2004, John 
Wiley & Sons, Inc. 
49 
 
 
44. Humphrey, W., A. Dalke, and K. Schulten, VMD: Visual molecular dynamics. Journal of 
Molecular Graphics, 1996. 14(1): p. 33-38. 
45. Fiser, A., R.K. Do, and A. Sali, Modeling of loops in protein structures. Protein Sci, 2000. 
9(9): p. 1753-73. 
46. Fiser, A. and A. Sali, ModLoop: automated modeling of loops in protein structures. 
Bioinformatics, 2003. 19(18): p. 2500-1. 
47. Morris, G.M., et al., AutoDock4 and AutoDockTools4: Automated Docking with Selective 
Receptor Flexibility. Journal of computational chemistry, 2009. 30(16): p. 2785-2791. 
48. Phillips, J.C., et al., Scalable Molecular Dynamics with NAMD. Journal of computational 
chemistry, 2005. 26(16): p. 1781-1802. 
49. Essmann, U., et al., A smooth particle mesh Ewald method. The Journal of Chemical 
Physics, 1995. 103(19): p. 8577-8593. 
50. Tuckerman, M., B.J. Berne, and G.J. Martyna, Reversible multiple time scale molecular 
dynamics. The Journal of Chemical Physics, 1992. 97(3): p. 1990-2001. 
50 
 
 
51. Gohlke, H., C. Kiel, and D.A. Case, Insights into Protein–Protein Binding by Binding Free 
Energy Calculation and Free Energy Decomposition for the Ras–Raf and Ras–RalGDS 
Complexes. Journal of Molecular Biology, 2003. 330(4): p. 891-913. 
52. Kim, H., et al., Structure-function studies of a plant tyrosyl-DNA phosphodiesterase provide 
novel insights into DNA repair mechanisms of Arabidopsis thaliana. Biochem J, 2012. 
443(1): p. 49-56. 
 
 
 
 
 
 
 
 
  
  
51 
 
 
2 CHAPTER 2. NETWORK ANALYSIS FOR EVOLUTION OF ALLOSTERIC 
COMMUNICATION IN 3-KETOSTEROID RECEPTORS 
2.1 INTRODUCTION 
2.1.1 Structure and Function of 3-ketosteroid receptors  
3-ketosteroid (3KS) receptors are a ubiquitous family of nuclear hormone receptors (NRs) 
that regulate multiple biological pathways by either up-regulating transcription via binding to a 
glucocorticoid response-activating element ((+)GRE) or down-regulating transcription via 
binding to a glucocorticoid response-repressing element (nGRE). After diverging from the latest 
common ancestor, Ancestral Steroid Receptor 2 (AncSR2) [1], members of the 3KS family have 
evolved varying binding affinities for (+)GRE and nGRE elements that act as allosteric effectors 
to influence protein structures and activity. [2] The mutations within the 3KS family cause no 
significant perturbation to the secondary structure of the DNA binding domain (DBD) of the 
receptor, making allosteric effects the most likely cause of differences in binding affinity 
between the homologues. [3]  
The 3KS DBD consists of two zinc fingers, a “reading helix,” responsible for making 
specific contacts along the major groove of the GRE, two semi-flexible loops known as the 
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D-box (distal box; see figure 2.1), and P-box (proximal box; see figure 2.1). The D-box is 
primarily involved in dimerization, while the P-box interacts with the DNA. [4] [5]  
2.1.2 Glucocorticoid Response Elements 
 (+)GREs consist of two hexameric, inverted half-sites that are separated by a three base 
pair spacer, causing the 3KS DBD to bind as a homodimer (figure 2.2). Studies indicate that the 
(+)GREs allosterically activates transcription [2, 5-7] by positively promoting the binding of a 
second monomer after one monomer binds. In contrast to (+)GREs, 3KS receptors bind to nGRE 
elements as monomers on opposing sides of the DNA duplex, with each monomer’s D-box 
facing away from the other, separated by a 0-2 base pair spacer (figure 2.2). [8, 9]       
2.1.3 Specific goal 
Although 3-Ketosteroid nuclear receptors share similar structure, evolutionary mutations 
occurring far from the dimerization and DNA binding interfaces cause differing GRE binding 
affinities. [10] Therefore, we have investigated allosteric communication within selected 
3-Ketosteroid DBD complexes, illustrating how network theory can be applied to elucidate the 
correlation between 3KS DBD binding characteristics and epistatic mutations. 
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2.2 METHOD 
2.2.1 Dynamic network analysis 
 Network theory is a broad field that can be applied to a diverse range of complex systems, 
such as social network or biological network analysis. A network is an analytically useful 
representation of a collection of interacting components (nodes) and the communication 
pathways between them (edges). In the case of protein-DNA systems, nodes are assigned to each 
protein α-carbon and phosphorus and C1’ atoms in nucleotides. An edge is placed between two 
nodes that are within a 4.5 Å cutoff for over 75% of the MD trajectory, with the weight of the 
edge between nodes i and j calculated as 𝑊!" = − log(|𝐶!"|) , where Cij is the cartesian 
covariance between the nodes, calculated from eq. 2.1 and 2.2. [11, 12] According to this 
network model, residues are defined to have strong correlation if their coordinates move in the 
same way. 
  (2.1)  
     
(2.2) 
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Here the expectation value represents time average, and is the cartesian position vector of the ith 
node at the time t. In practice, these covariance values are calculated for every node pair in the 
complex and organized in a covariance matrix from which the network data is derived.  
2.2.2 Selected analysis methodologies for dynamical networks  
Within a network, nodes tend to organize into clusters with dense intra-cluster connections.  
These clusters are known as communities and yield insight into the global structure of the 
network communication pathways. There are many ways to organize a network into communities, 
with one of the more rigorous being the Girvan-Newman (GN) algorithm. [12, 13] In GN, the 
shortest communication pathway between every node pair (the optimal path) is first determined, 
based on edge weight. i.e. A very heavily weighted edge is conceptually shorter than a lighter 
edge. Next, an edge is assigned a betweenness value that reflects the number of optimal paths 
that proceed through it. The algorithm then begins removing edges, starting with those 
possessing the highest betweenness, assessing the modularity (Q, eq. 2.3) after removing each 
edge. [14] 
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(2.3)
 
Here, 𝐴!"  is an adjacency matrix (𝐴!" = 1  if node 𝑖 and node 𝑗 are connected, otherwise 
𝐴!" = 0), 𝐾! and 𝐾! is degree of node 𝑖 and 𝑗 to present the number of edges at each node, 
and 𝑚 is the total number of the edges in the network. After nodes are assigned to communities, 
the betweennesses of the edges that lie between communities can be summed over, producing a 
quantitative total-betweenness value that describes how closely intertwined two communities are. 
For example, a pair of communities that exhibit a very high total-betweenness can be considered 
close to merging into a single community. 
2.3 EXPERIMENTAL PROCEDURE 
 Here we investigate allosteric signal transduction in (+)GRE complexes for six 3KS family 
members: AncSR2, Ancestral Glucocorticoid Receptor (AncGR), Ancestral Glucocorticoid 
Rreceptor 2 (AncGR2), the human Glucocorticoid Receptor (hGR), Ancestral Mineralocorticoid 
Receptor (AncMR), and the human Mineralocorticoid Receptor (hMR); and in nGRE complexes 
for the hGR and AncSR2 homologues. The unpublished crystal structures for these complexes 
were provided by the Ortlund group at Emory University. All systems were solvated in a 0.1M 
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NaCl, TIP3P waterbox with 10Å distances between the edges of the solute and the box. 
Simulations were run using the molecular dynamics program NAMD 2.9 [15] with the amber 
ff99SB-parmbsc0 force field [16]. Bonded and short-range interactions were evaluated every 2fs, 
with long-range electrostatics evaluated every 4 fs with the smooth particle mesh ewald method 
[17]. Short-range nonbonded interactions were evaluated using a 10Å cutoff with a switching 
function at 8.5 Å. The r-RESPA [18] multiple timestep integration scheme was employed with a 
2fs timestep and SHAKE employed to fix bonds between hydrogens and heavy atoms. Each 
system was subjected to 10,000 steps of conjugate gradient minimization, followed by 100ps of 
dynamics in the NVT ensemble, during which the system was heated from 0 to 300 K with 
positional restraints applied to the solute. Finally, 7 NPT ensemble simulations were performed 
at 1 atm for 1ns, with each stage incrementally releasing the positional restraints, first on the 
protein, followed by the DNA, with sidechains and bases released before backbone atoms. 220ns 
of unrestrained NPT was performed, with the beginning 20ns discarded as equilibration, 
resulting in 200ns of trajectory used in the analysis. [6, 19, 20] 
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2.4 RESULTS AND DISCUSSION 
2.4.1 Sequence alignment and evolution tree 
We have inferred the relative binding affinities of many members of the 3KS family to 
(+)GRE and nGRE elements from two experimental lines of evidence: florescence anisotropy 
probes and luciferase assays. Figure 2.3 displays the results of the fluorescence anisotropy 
experiments. The results show little difference in (+)GRE binding for most of the homologues, 
with the exception of the hMR variant that exhibits lower affinity than the rest, while the nGRE 
binding data shows conclusively that AncGR2 and hGR are the homologues shown that bind to 
nGRE elements with substantial affinity.  
Luciferase reporter activity in HeLa cells shows that the orders for (+)GRE activation (figure 
2.4) and nGRE repression (figure 2.5) for the 3KS homologues are AncGR > AncGR2 > hGR > 
AncSR2 ~ AncMR > hMR and AncGR2 ~ hGR > AncSR2 ~ AncGR > AncMR ~ hMR ~ 0, 
respectively. This data has been incorporated into the phylogenetic tree in figure 2.6 in order to 
highlight the role of epistasis in this evolutionary pathway. From multiple sequence alignment of 
3-ketosteroid receptor DBDs within GR and MR lineage, these DBDs are highly conserved with 
few mutations leading to functional changes (figure 2.7). In order to determine activation and 
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repressive abilities of ancestral DBDs, the homologous sequences studied here were generated 
via ancestral protein resurrection (APR) to reconstruct and characterize the DBDs of its ancestral 
proteins from finding maximum-likehood phylogenetics, followed by experimental synthesis, 
expression, and characterization. 
2.4.2 Correlation network analysis 
Dynamical networks and community organizations were calculated for the 3KS systems as 
described in the methodology section. The community structures, namely the creation and 
ablation of communities by evolution, are powerfully retrodictive.   
The first phenomenon of interest in analyzing the network structures presented in figure 2.8 
is the annihilation and re-creation of the community representing only the 3 base pair spacer (S 
community) in the (+)GRE DNA duplex along the GR branch of the 3KS phylogeny. The spacer 
makes no contact to the protein homodimer and is recognized by the GN algorithm as a 
semi-independent body (figure 2.8 and figure 2.9). From AncSR2 to AncGR, this community 
disappears, having been absorbed into the neighboring communities. The disappearance of the 
spacer community is due to its increased betweenness. Because AncGR has the highest affinity 
for (+)GRE elements of any 3KS receptor studied, one concludes that communication through 
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the DNA increases substantially with binding affinity. The spacer community reappears upon the 
evolution of AncGR2, coincident with a slight decrease in binding affinity. The strength of the 
betweennesses associated with the spacer community throughout the 3KS phylogeny exactly 
mirrors the binding affinity trend.  Tracking along the GR branch of the 3KS phylogeny, one 
observes a strong increase in nGRE binding affinity occurs with the G425S mutation. However, 
this mutation has a strong epistatic relationship with those preceding it; introducing G425S in 
AncSR2 does not significantly impact nGRE binding affinity. This epistasis is clearly 
represented in figure 2.8 as the creation of community Υ. The creation of community Υ	  lays the 
dynamical foundation necessary for the G425S mutant to impact allostery. Specifically, the 
I423V mutation (figure 2.10) appears to be strongly associated with the bifurcation of 
communities β and Υ. The I423 variant presses the β-sheet and helix 3 structural elements 
together, fusing them into a single community. Introducing V423 decreases this hydrophobic 
packing, forming a new community. This change is relatively insignificant in (+)GRE element 
binding affinity, but clearly impacts nGRE binding (figure 2.11). In hGR, a portion of the nGRE 
DNA duplex becomes so closely associated with the community created by the I423V and 
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G425S that it merges into the protein monomer, illustrating an immense increase in 
communication through the DNA, and therefore monomer binding cooperativity.   
Finally, while the homologues along the GR branch share many commonalities, the MR 
branch displays a large number of community divergences, fracturing the allosteric cohesiveness 
of the complex. This fracturing ablates nGRE binding activity and reduces (+)GRE binding 
activity, indicating that a relatively small number of well-organized communities results in 
stronger allosteric pathways throughout the complex and stronger binding affinity. 
Colors are assigned by communities, and values between nodes are betweennesses.   
  Some studies[8, 21, 22] indicate that dimerization interface is also crucial in GR DBD to 
transmit information. One mutation, A477T, located at the dimerization interface can disrupt this 
pathway and abolish the GR activity. We can observe the A477 residue pops up the community 
for the other receptor monomer within GR and MR linage (Figure 2.12), so we can see how 
important this A477 residue is in the dimerization.  
2.5 CONCLUSIONS 
    The community structures of the 3KS homologues are indicative of their binding affinities 
and clearly highlight the epistatic preconditions required for nGRE binding enhancement by the 
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G425S mutation. We have found that community creation and deletion are closely associated 
with binding affinity and that the community analysis method is sensitive enough to exactly 
reproduce binding affinity trends in NRs. More specifically, some community bifurcations are 
necessary for allosteric alterations (the GR lineage), while a poorly organized and incoherent 
community structure negatively impacts binding affinity by deleteriously affecting 
intra-monomer and intra-complex allosteric communication. The evolution of the 3KS receptor 
family is a very illustrative example of how mutations that occur far from any functionally 
important regions of a protein (in this case, dimerization or DNA-binding interfaces) can alter 
protein function by altering the underlying, inherent allosteric organization of the protein. We 
have shown that community analysis are very powerful retrodictive tools and the work herein 
describes certain community structure attributes that could be used in future work to predict 
changes in protein function. 
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Figure 2.1 Secondary structure of the 3KS DBD. 
(a) Crystal structure of hGR DBD colored by functional domains as represented in (b). (PDB ID: 
1R4O)  
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Figure 2.2 General mechanisms of receptor action. 
GR binds to (+)GREs as a homodimer (left), while it binds cooperatively as monomers to nGREs 
(right). 
 
 
Figure 2.3 Fluorescence anisotropy of selected 3KS homologues. 
3KS fluorescence anisotropy in the presence of (+)GRE (left) and thymic stromal lymphopoeitin 
associated nGRE (right). The (+)GRE construct for binding used was  
5’-(FAM)CCAGAACAGAGTGTTCTGA-3’; 5’-TCAGAACACTCTGTTCTGG-3’ and the 
nGRE probe was 5’-(FAM)CCGCCTCCGGGAGAGCTG-3’; 5’-CAGCTCTCCCGGAGGCGG 
-3.  
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Figure 2.4 (+)GRE associated luciferase activity in the presence of selected 3KS 
homologues. 
Experimental presentation for determination of transactivation ability of ancestral DBDs by dual 
luciferase reporter assays. Luciferase reporter activity when associated with (+)GRE, higher 
reporter activity indicates higher affinity. 
 
 
Figure 2.5 nGRE associated luciferase activity in the presence of selected 3KS homologues. 
Luciferase reporter activity when associated with thymic stromal lymphopoeitin nGRE, lower 
reporter activity indicates higher affinity. 
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Figure 2.6 3KS phylogenetic tree. 
The left semi-circle represents the (+)GRE binding affinity, while the right semi-circle represents 
nGRE binding affinity. Fully colored indicates high binding affinity, while half-colored indicates 
low biding affinity. Stems are labeled with their associated mutations.  
 
 
Figure 2.7 Multiple sequence alignment of 3-ketosteroid family of DBDs within GR and 
MR lineage. 
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Figure 2.8 Network structures and graphs in (+)GRE-bound 3KS homologues GR linege. 
Each panel is labeled with the 3KS homologue represented within the panel. The left portion of 
each panel is a structure of the homologue, colored by community. The right portion of each 
(a) AcnSR2 
(b) AncGR 
(c) AncGR2 
(d) GR 
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panel is a simplified graph representation of the community structure, with edges weighted and 
labeled by betweenness.   
 
 
Figure 2.9 Network structures and graphs in (+)GRE-bound 3KS homologues MR lineage. 
Each panel is labeled with the 3KS homologue represented within the panel. The left portion of 
each panel is a structure of the homologue, colored by community. The right portion of each 
panel is a simplified graph representation of the community structure, with edges weighted and 
labeled by betweenness.   
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68 
 
 
 
Figure 2.10 I423V causes a community bifurcation. 
V423 alters hydrophobic packing, creating a new community (purple). 
 
 
(a) (b) 
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Figure 2.11 Network structures and graphs in nGRE-bound AncSR2 and GR. 
Each panel is labeled with the 3KS homologue represented within the panel. The left portion of 
each panel is a structure of the homologue, colored by community. The right portion of each 
panel is a simplified graph representation of the community structure, with edges weighted and 
labeled by betweenness.  
  
(a) AncSR2 
(b) GR 
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Figure 2.12 Comparison of A477 in (a) AncSR2, (b) GR, and (c) MR systems. 
A477 located at the dimerization interface is involved in the community that spans receptor 
monomers implicating a strong communication between two monomers via A477. 
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GENERAL CONCLUSIONS 
This thesis has been dedicated to the computational studies in the discovery of potential 
TDP1-selective inhibitors and allosteric communication in the selected evolutionary 3KS 
receptors.  
TDP1 is a cellular enzyme involved in repair of Top1 cleavage complexes generated by the 
block of Top1 inhibitors, such as camptothecins, resulting in DNA damage for anti-cancer drugs, 
and camptothecin is hypersensitive in TDP1-defective cells, so development of TDP1-selective 
inhibitors is emerging to improve response in chemotherapeutics. In present studies, there is no 
specific TDP1 inhibitor with high inhibitory activity, and its binding site is unknown. According 
to binding mode analysis of our lead compound, NSC 339616, we have found the TDP1 inhibitor 
is well accommodated in the DNA-binding cleft through the hydrophilic and stable hydrogen 
bonding interactions and sandwich interactions with hydrophobic residues. Furthermore, 
potential TDP1-selective inhibitor candidates are identified by using ligand-based virtual 
screening based on a comparison of three-dimensional shape and electrostatic potential from 
large library of molecules. 
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3KS receptors cooperatively bind to (+)GRE and nGRE that allosterically activates and 
suppresses transcription, respectively. In evolution of 3KS, some epistatic mutations cause 
changes in allosteric communications resulting in altered binding affinities. Such allostery has 
been studied but not been analyzed and quantified from the field of network theory. We have 
shown correlation network and community analysis are very powerful tools to predict changes in 
binding affinities via quantification of communications between communities and illustrated the 
epistatic relationship between I423V and G425S mutations in the 3KS homologues for nGRE 
binding enhancement.  
The computational methods using in this thesis have displayed efficiency, accuracy, and 
how it bridges gaps between theory and reality, being performed in future work to discover drugs 
or predict changes in protein binding function. 
 
